Natal

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Lung cancer2 trials
• Metastatic breast cancer2 trials
• Childhood cancers1 trial
• IgA nephropathy1 trial

Phase

• Phase 22 trials
• Phase 32 trials
• Phase 42 trials

Status

• Active, not recruiting2 trials
• Completed2 trials
• Recruiting2 trials

Lead sponsor

• Novartis Pharmaceuticals6 trials

Running trials

• Recruiting

  A Study to Assess the Effects of Zigakibart on IgA Nephropathy.

  NCT07146906· Phase 2· Novartis Pharmaceuticals· Source

  Contact: Novartis Pharmaceuticals

• Recruiting

  Study to Assess the Pharmacokinetics, Safety, and Tolerability of Iptacopan in Pediatric PNH Patients

  NCT06934967· Phase 3· Novartis Pharmaceuticals· Source

  Contact: Novartis Pharmaceuticals

• Active, not recruiting

  Roll-over Study to Allow Continued Access to Ribociclib

  NCT05161195· Phase 4· Novartis Pharmaceuticals· Source

• Active, not recruiting

  Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib Treatment in a Novartis-sponsored Study

  NCT02584933· Phase 4· Novartis Pharmaceuticals· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• IgA nephropathy1 recruiting

Closed trials

• Completed

  Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer

  NCT03822468· Phase 2· Novartis Pharmaceuticals· Source

• Completed

  LDK378 Versus Chemotherapy in Previously Untreated Patients With ALK Rearranged Non-small Cell Lung Cancer

  NCT01828099· Phase 3· Novartis Pharmaceuticals· Source